Morpholino

MO1-cdkn2aip

ID

ZDB-MRPHLNO-180124-1

Name

MO1-cdkn2aip

Previous Names

None

Target

cdkn2aip (1)

Sequence

5' - CCTCTTCTTGCCGCCATCACTCTAA - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Translation-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-cdkn2aip

Expressed Gene	Anatomy	Figures
cdx4	presumptive ventral mesoderm	Fig. 4 from He et al., 2017
myb	hematopoietic stem cell	Fig. 5 from He et al., 2017
tbx6	presumptive ventral mesoderm	Fig. 4 from He et al., 2017

Phenotype

Phenotype resulting from MO1-cdkn2aip

Phenotype	Fish	Figures
canonical Wnt signaling pathway decreased process quality, abnormal	ia4Tg + MO1-cdkn2aip	Fig. 4 from He et al., 2017
definitive hemopoiesis decreased occurrence, abnormal	TU + MO1-cdkn2aip	Fig. 5 from He et al., 2017
hematopoietic stem cell myb expression decreased amount, abnormal	TU + MO1-cdkn2aip	Fig. 5 from He et al., 2017
presumptive ventral mesoderm cdx4 expression decreased amount, abnormal	TU + MO1-cdkn2aip	Fig. 4 from He et al., 2017
presumptive ventral mesoderm tbx6 expression decreased amount, abnormal	TU + MO1-cdkn2aip	Fig. 4 from He et al., 2017
whole organism GFP expression decreased amount, abnormal	ia4Tg + MO1-cdkn2aip	Fig. 4 from He et al., 2017

Phenotype of all Fish created by or utilizing MO1-cdkn2aip

Phenotype	Fish	Conditions	Figures
presumptive ventral mesoderm cdx4 expression decreased amount, abnormal	TU + MO1-cdkn2aip	control	Fig. 4 from He et al., 2017
hematopoietic stem cell myb expression decreased amount, abnormal	TU + MO1-cdkn2aip	control	Fig. 5 from He et al., 2017
canonical Wnt signaling pathway decreased process quality, abnormal	TU + MO1-cdkn2aip	control	Fig. 4 from He et al., 2017
presumptive ventral mesoderm tbx6 expression decreased amount, abnormal	TU + MO1-cdkn2aip	control	Fig. 4 from He et al., 2017
definitive hemopoiesis decreased occurrence, abnormal	TU + MO1-cdkn2aip	control	Fig. 5 from He et al., 2017
canonical Wnt signaling pathway decreased process quality, abnormal	ia4Tg + MO1-cdkn2aip	control	Fig. 4 from He et al., 2017
whole organism GFP expression decreased amount, abnormal	ia4Tg + MO1-cdkn2aip	control	Fig. 4 from He et al., 2017
definitive hemopoiesis decreased occurrence, abnormal	tp53^zdf1/zdf1 + MO1-cdkn2aip	control	Fig. 5 from He et al., 2017
hematopoietic stem cell myb expression decreased amount, abnormal	tp53^zdf1/zdf1 + MO1-cdkn2aip	control	Fig. 5 from He et al., 2017
canonical Wnt signaling pathway decreased process quality, abnormal	TU + MO1-cdkn2aip + MO1-wnt8a + MO2-wnt8a	control	Fig. 4 from He et al., 2017
presumptive ventral mesoderm cdx4 expression decreased amount, abnormal	TU + MO1-cdkn2aip + MO1-wnt8a + MO2-wnt8a	control	Fig. 4 from He et al., 2017
presumptive ventral mesoderm tbx6 expression decreased amount, abnormal	TU + MO1-cdkn2aip + MO1-wnt8a + MO2-wnt8a	control	Fig. 4 from He et al., 2017
presumptive ventral mesoderm cdx4 expression decreased amount, abnormal	TU + MO1-cdkn2aip + MO1-wnt8a + MO2-wnt8a + MO7-tp53	control	Fig. 4 from He et al., 2017
canonical Wnt signaling pathway decreased process quality, abnormal	TU + MO1-cdkn2aip + MO1-wnt8a + MO2-wnt8a + MO7-tp53	control	Fig. 4 from He et al., 2017
presumptive ventral mesoderm tbx6 expression decreased amount, abnormal	TU + MO1-cdkn2aip + MO1-wnt8a + MO2-wnt8a + MO7-tp53	control	Fig. 4 from He et al., 2017
ventral wall of dorsal aorta hematopoietic stem cell decreased amount, abnormal	y206Tg; zf169Tg + MO1-cdkn2aip	control	Fig. 5 from He et al., 2017

Citations